Total Payments
$4,991
2024 Payments
$650.53
Companies
39
Transactions
337
Medicare Patients
4,136
Medicare Billing
$326,232
Payment Breakdown by Category
Food & Beverage$4,991 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,991 | 337 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,273 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $766.61 | 41 | $0 (2024) |
| Lilly USA, LLC | $471.29 | 37 | $0 (2024) |
| PFIZER INC. | $280.26 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $221.62 | 14 | $0 (2024) |
| Abbott Laboratories | $216.74 | 12 | $0 (2024) |
| Amgen Inc. | $215.97 | 15 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $213.21 | 19 | $0 (2021) |
| ABBVIE INC. | $204.21 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $189.52 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $650.53 | 32 | Novo Nordisk Inc ($174.96) |
| 2023 | $646.71 | 40 | Novo Nordisk Inc ($201.85) |
| 2022 | $912.11 | 71 | Novo Nordisk Inc ($226.43) |
| 2021 | $771.57 | 54 | Novo Nordisk Inc ($204.99) |
| 2020 | $409.68 | 27 | Novo Nordisk Inc ($161.71) |
| 2019 | $314.19 | 22 | Novo Nordisk Inc ($65.51) |
| 2018 | $500.58 | 39 | Novo Nordisk Inc ($147.55) |
| 2017 | $785.71 | 52 | AstraZeneca Pharmaceuticals LP ($187.01) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 2 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINES | ||||||
| 02/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 01/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Inflammation | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: DIABETES | ||||||
| 12/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: DIABETES | ||||||
| 11/13/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PAIN | ||||||
| 11/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Inflammation | ||||||
| 11/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Biological | ||||||
| 10/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Obesity | ||||||
| 10/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINES | ||||||
| 10/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: INSOMNIA | ||||||
| 09/12/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 09/07/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Inflammation | ||||||
| 09/05/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Diabetes | ||||||
| 08/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN | ||||||
| 08/04/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,129 | 1,841 | $190,352 | $95,354 |
| 2022 | 16 | 896 | 1,537 | $153,481 | $51,261 |
| 2021 | 19 | 908 | 1,567 | $161,917 | $80,104 |
| 2020 | 22 | 1,203 | 2,622 | $246,598 | $99,513 |
Total Patients
4,136
Total Services
7,567
Medicare Billing
$326,232
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 516 | $85,140 | $39,710 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 269 | $30,397 | $15,232 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 106 | 106 | $17,172 | $12,709 | 74.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 106 | 106 | $13,250 | $8,197 | 61.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 53 | 55 | $5,500 | $4,088 | 74.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 32 | 140 | $8,960 | $3,729 | 41.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $4,700 | $3,309 | 70.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 99 | 101 | $2,525 | $2,450 | 97.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 81 | 190 | $8,360 | $1,801 | 21.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,563 | $1,526 | 59.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 17 | $2,975 | $807.34 | 27.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 11 | 12 | $1,176 | $665.88 | 56.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 46 | $2,070 | $415.20 | 20.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 51 | 52 | $2,496 | $317.72 | 12.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 20 | 44 | $660.00 | $193.09 | 29.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 35 | 43 | $688.00 | $140.46 | 20.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 86 | $1,720 | $62.13 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 423 | $69,795 | $18,086 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 312 | $35,256 | $12,660 | 35.9% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 37 | 172 | $11,008 | $4,752 | 43.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 59 | 59 | $5,900 | $4,145 | 70.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 54 | 61 | $4,575 | $2,495 | 54.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 80 | $2,000 | $1,962 | 98.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $7,290 | $1,753 | 24.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 67 | 172 | $7,568 | $1,641 | 21.7% |
About Dr. William Davito, D.O
Dr. William Davito, D.O is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164417515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Davito, D.O has received a total of $4,991 in payments from pharmaceutical and medical device companies, with $650.53 received in 2024. These payments were reported across 337 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,991).
As a Medicare-enrolled provider, Davito has provided services to 4,136 Medicare beneficiaries, totaling 7,567 services with total Medicare billing of $326,232. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Adolescent Medicine
- Location Bartlesville, OK
- Active Since 09/13/2005
- Last Updated 01/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164417515
Products in Payments
- Ozempic (Drug) $538.54
- FARXIGA (Drug) $362.39
- JARDIANCE (Drug) $241.76
- Rybelsus (Drug) $226.33
- TRULICITY (Drug) $200.22
- Victoza (Drug) $197.94
- XARELTO (Drug) $177.22
- BYDUREON (Drug) $152.46
- MOUNJARO (Drug) $151.92
- JANUVIA (Drug) $129.21
- UBRELVY (Drug) $111.66
- NURTEC ODT (Drug) $101.78
- AIRSUPRA (Drug) $92.18
- Otezla (Drug) $92.09
- Myrbetriq (Drug) $91.25
- FREESTYLE LIBRE 3 (Device) $91.14
- FREESTYLE LIBRE 2 (Device) $87.84
- QULIPTA (Drug) $79.85
- PREVNAR 20 (Biological) $79.08
- BREZTRI (Drug) $77.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Family Medicine $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Family Medicine $6,925
Dr. Daniel Holdman, Md, MD
Family Medicine — Payments: $5,612
Family Medicine $5,612
Michael Vaclaw, M.d, M.D
Family Medicine — Payments: $4,027
Family Medicine $4,027
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276
Family Medicine $3,276
Gerald Pribil, Md, MD
Family Medicine — Payments: $2,266
Family Medicine $2,266